• Latest Posts

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

These are our 10 Most Read Biotech Articles of 2016

Our Startup Battle Winner uses CRISPR in a Whole New Way

UPDATE: No Clear Winner in the CRISPR Patent Battle

ADVERTISEMENT

Evotec gets hold of CRISPR in a new Partnership with Merck

CRISPR meets RNAi: a whole new Targeted Therapy

Swiss SynBio adds CRISPR to its Toolkit for new Specialty Chemicals

CRISPR Thx’ surprisingly low IPO… why are Investors Discouraged?

The CRISPR Revolution is here, but how can we make it Useful?

ADVERTISEMENT